Are Globus Medical Inc’s (GMED) stock prices rising too high?
BTIG Research raised the price target for the Globus Medical Inc (NYSE:GMED) stock from “a Neutral” to “a Buy”. The rating was released on March 18, 2024, according to finviz. The research report from Stifel has upgraded the stock from Hold to Buy, with a price target set at $61. The stock was upgraded by […]
Globus Medical Inc (GMED) Stock Experiences Incredible Growth
BTIG Research raised the price target for the Globus Medical Inc (NYSE:GMED) stock from “a Neutral” to “a Buy”. The rating was released on March 18, 2024, according to finviz. The research report from Stifel has upgraded the stock from Hold to Buy, with a price target set at $61. The stock was upgraded by […]
Globus Medical Inc (GMED) Stock deserves your attention
BTIG Research raised the price target for the Globus Medical Inc (NYSE:GMED) stock from “a Neutral” to “a Buy”. The rating was released on March 18, 2024, according to finviz. The research report from Stifel has upgraded the stock from Hold to Buy, with a price target set at $61. The stock was upgraded by […]
Hold on to your shares: Globus Medical Inc (GMED) Stock
BTIG Research raised the price target for the Globus Medical Inc (NYSE:GMED) stock from “a Neutral” to “a Buy”. The rating was released on March 18, 2024, according to finviz. The research report from Stifel has upgraded the stock from Hold to Buy, with a price target set at $61. The stock was upgraded by […]
Globus Medical Inc (NYSE:GMED) Stock Price Settled at $50.75: What’s Resulting?
BTIG Research raised the price target for the Globus Medical Inc (NYSE:GMED) stock from “a Neutral” to “a Buy”. The rating was released on March 18, 2024, according to finviz. The research report from Stifel has upgraded the stock from Hold to Buy, with a price target set at $61. The stock was upgraded by […]